Simplex Trading
TTNP

Simplex Trading’s Titan Pharmaceuticals TTNP Stock Holding History

Simplex Trading’s Portfolio TTNP Stock Details TTNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-24
Closed -$620 – 10914
2022
Q2 		$0 Buy
24
+6
+33% +$75 ﹤0.01% 11131
2022
Q1 		$0 Sell
18
-172
-91% -$3.57K ﹤0.01% 11422
2021
Q4 		$3K Buy
+190
New +$5.73K ﹤0.01% 9881
2021
Q2 		– Sell
-152
Closed -$7.6K – 10730
2021
Q1 		$9K Buy
+152
New +$10.1K ﹤0.01% 7973
2020
Q3 		– Sell
-3
Closed -$463 – 8539
2020
Q2 		$0 Buy
+3
New +$517 ﹤0.01% 8380
2020
Q1 		– Sell
-3
Closed -$469 – 8298
2019
Q4 		$0 Buy
+3
New +$361 ﹤0.01% 7997
2018
Q2 		– Hold
0
– – – 7902
2018
Q1 		– Hold
0
– – – 6892
2017
Q4 		– Hold
0
– – – 6710
2017
Q3 		– Hold
0
– – – 6665
2017
Q2 		– Hold
0
– – – 5747
2017
Q1 		– Sell
-1
Closed -$14.1K – 5350
2016
Q4 		$8K Buy
+1
New +$16.8K ﹤0.01% 3954
2016
Q3 		– Sell
-1
Closed -$19.4K – 6466
2016
Q2 		$11K Buy
+1
New +$21.3K ﹤0.01% 3537
2016
Q1 		– Hold
0
– – – 3831
2015
Q4 		– Hold
0
– – – 5016

Other funds holding TTNP

Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
LFA
Level Financial Advisors East Amherst, New York $448M AUM 16.6% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Simplex Trading's TTNP Position: Q3 2022 in Review

Simplex Trading sold out of Titan Pharmaceuticals (TTNP) in Q3 2022, closing a stake of 24 shares — an estimated $620 sold.

Simplex Trading first reported a position in TTNP in Q2 2016 and held it in 8 quarters. The position peaked at $11K in Q2 2016. 18 funds tracked by Wall St. Rank hold TTNP as of Q3 2022.

  • Simplex Trading reported no remaining Titan Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Simplex Trading sold 24 Titan Pharmaceuticals shares in Q3 2022, an estimated $620.
  • Simplex Trading first reported a position in Titan Pharmaceuticals in Q2 2016 and held it in 8 quarters.
  • Simplex Trading's Titan Pharmaceuticals position peaked at $11K in Q2 2016.
  • 18 funds tracked by Wall St. Rank held Titan Pharmaceuticals as of Q3 2022.

Based on Simplex Trading's 13F filing for Q3 2022, filed 4 Nov 2022.